The clinical effectiveness and costeffectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: Systematic reviews, registry database analyses and economic evaluation

Review finds that surveillance following treatment of primary breast cancer is likely to improve patient survival, with a strategy of mammography alone every 12–24 months appearing to have the highest net benefits. To optimise the use of resources and achieve maximum patient benefit, women at a higher risk of developing ipsilateral breast tumour recurrence or metachronous contralateral breast cancer should be offered more comprehensive and more frequent surveillance